StemVax's Corporate Minority Round

StemVax raised a round of funding on July 18, 2018. Investors include Innovest Global.

StemVax Therapeutics is a translational biotechnology company that develops therapies for brain tumor patients.…

Articles about StemVax's Corporate Minority Round: